Skip to content
Ask Dr. Calapai
The Stem Cell Foundation
  • Home
  • About Us
  • Videos
  • Articles
  • Donate
  • Contact Us
  • Toggle website search
Menu Close
  • Home
  • About Us
  • Videos
  • Articles
  • Donate
  • Contact Us
  • Toggle website search

Blog

  1. Home>
  2. 2017>
  3. September>
  4. 11>
  5. Articles>
  6. A Descriptive Study on The Safety and Efficacy of Mesenchymal Stem Cell Therapy For Parkinson’s Disease: A Case Series

A Descriptive Study on The Safety and Efficacy of Mesenchymal Stem Cell Therapy For Parkinson’s Disease: A Case Series

  • Post author:2by2host
  • Post published:September 11, 2017
  • Post category:Articles / Stem Cells

main.pdf

Please Share This Share this content

  • Opens in a new window Twitter
  • Opens in a new window Facebook
  • Opens in a new window Google+
  • Opens in a new window Pinterest
  • Opens in a new window LinkedIn
  • Opens in a new window Viber
  • Opens in a new window VK
  • Opens in a new window Reddit
  • Opens in a new window Tumblr
  • Opens in a new window Viadeo
  • Opens in a new window WhatsApp

You Might Also Like

Selenium deficiency impairs corticosterone and leptin responses to adrenocorticotropin in the rat

December 28, 2006

Metallothionein–a promising tool for cancer diagnostics.

February 21, 2013

A prospective multi-site registry study of a specific protocol of autologous bone marrow concentrate for the treatment of shoulder rotator cuff tears and osteoarthritis

September 29, 2017

Categories

  • Articles
  • Stem Cells
  • Videos

Recent Posts

  • Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party
  • Update on mesenchymal stem cell-based therapy in lupus and scleroderma
  • Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
  • Mesenchymal Stem Cells Are Recruited into Wounded Skin and Contribute to Wound Repair by Transdifferentiation into Multiple Skin Cell Type
  • The safety of bone-marrow derived mesenchymal stem cells in patients with type 2 diabetes mellitus

Follow Us

Copyright 2023